Strathspey Crown Holdings Group LLC 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-22 4:37 pm Sale |
2023-08-11 | 13D | AEON Biopharma, Inc. AEON |
Strathspey Crown Holdings Group LLC | 28,219 5.470% |
-102,619 (-78.43%) |
Filing |
| 2023-07-31 4:45 pm Purchase |
2023-07-21 | 13D | AEON Biopharma, Inc. AEON |
Strathspey Crown Holdings Group LLC | 130,838 25.400% |
130,838 (New Position) |
Filing |